Skip to main content

Advertisement

SpringerLink
Log in

Cerebral Vasculitis

Diagnosis and Current Treatment Recommendations

  • Practical Therapeutics
  • Published:
CNS Drugs Aims and scope Submit manuscript

Summary

The vasculitides are a heterogeneous group of disorders that involve inflammation, necrosis and, ultimately, occlusion of blood vessels. They can have variable CNS involvement, with some, such as isolated angiitis of the CNS (IACNS) and Takayasu’s arteritis, predominantly or exclusively involving the CNS, while others only occasionally cause neurological complications. The latter syndromes include Wegener’s granulomatosis, systemic lupus erythematosus and disorders that mimic vasculitis such as the antiphospholipid antibody syndrome.

The treatment of vasculitides is generally with variable doses of corticosteroids and immunosuppressants. Prednisone (oral) and methylprednisolone (usually intravenous) are the most commonly used corticosteroids. Cyclophosphamide is one of the most potent drugs available to treat severe, life-threatening vasculitis. It is given as an oral or intravenous single daily dose regimen or as intravenous pulse therapy. The folate antagonist methotrexate is a useful steroid-sparing agent, and is often added to a corticosteroid regimen. Azathioprine, chlorambucil and cyclosporin have also been used for the treatment of vasculitis, but experience with these agents is limited. Newer therapies with possible, but still unproven, efficacy are intravenous immunoglobulin and monoclonal antibodies. Although general treatment guidelines can be suggested, treatment should be individualised for each vasculitic syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lie JT. Diagnostic histopathology of major systemic and pulmonary vasculitic syndromes. Rheum Dis Clin North Am 1990; 16: 269–92

    PubMed  CAS  Google Scholar 

  2. Cohen Tervaert JW, Kallenberg C. Neurologic manifestations of systemic vasculitides. Rheum Dis Clin North Am 1993; 19: 913–40

    Google Scholar 

  3. Moore PM, Cupps TR. Neurologic complications of vasculitis. Ann Neurol 1983; 14: 155–67

    Article  PubMed  CAS  Google Scholar 

  4. Moore PM, Fauci AS. Neurologic manifestations of systemic vasculitis. Am J Med 1981; 71: 517–24

    Article  PubMed  CAS  Google Scholar 

  5. Tsokos GC, Tsokos M, Le Riche NGH, et al. A clinical and pathologic study of cerebrovascular disease in patients with SLE. Semin Arthritis Rheum 1986; 16: 70–8

    Article  PubMed  CAS  Google Scholar 

  6. Vollertsen RS, Conn DL, Ballard DJ, et al. Rheumatoid vasculitis: survival and associated risk factors. Medicine 1986; 65: 365–75

    Article  PubMed  CAS  Google Scholar 

  7. Berlit P, Moore PM, Bluestein HG. Vasculitis, rheumatic disease and the neurologist: the pathophysiology and diagnosis of neurologic problems in systemic disease. Cerebrovasc Dis 1993; 3: 139–45

    Article  Google Scholar 

  8. Greenan TJ, Grossman RI, Goldberg HI. Cerebral vasculitis: MR imaging and angiographic correlation. Radiology 1992; 182: 65–72

    PubMed  CAS  Google Scholar 

  9. Sibbitt WL, Sibbitt RR. Magnetic resonance spectroscopy and positron emission tomography scanning in neuropsychiatric SLE. Rheum Dis Clin North Am 1993; 19: 851–68

    PubMed  Google Scholar 

  10. Taylor HG, Samanta A. Treatment of vasculitis. Br J Clin Pharmacol 1993; 35: 93–104

    Article  PubMed  CAS  Google Scholar 

  11. Boumpas DT. Glucocorticoid therapy for immune mediated diseases. Basic and clinical correlates. Ann Intern Med 1993; 119: 1198–208

    PubMed  CAS  Google Scholar 

  12. Hoffman GS, Leavitt RY, Fleisher TA, et al. Treatment of Wegener’s granulomatosis with intermittent high-dose intravenous cyclophosphamide. Am J Med 1990; 89: 403–10

    Article  PubMed  CAS  Google Scholar 

  13. Reinhold-Keller E, Kekow J, Schnabel A, et al. Influence of disease manifestation and ANCA titer on the response to pulse cyclophosphamide therapy in patients with Wegener’s granulomatosis. Arthritis Rheum 1994; 37: 919–24

    Article  PubMed  CAS  Google Scholar 

  14. Luce JK, Simons JA. Efficacy of Mesna in preventing further cyclophosphamide induced hemorrhagic cystitis. Med Pediatr Oncol 1988; 16: 372–4

    Article  PubMed  CAS  Google Scholar 

  15. Hoffman GS, Leavitt RY, Kerr GS, et al. The treatment of Wegener’s granulomatosis with glucocorticoids and methotrexate. Arthritis Rheum 1992; 35: 1322–9

    PubMed  CAS  Google Scholar 

  16. Krall PL, Mazanex DJ, Wilke WS. Methotrexate for corticosteroid resistant polymyalgia rheumatica and giant cell arteritis. Cleve Clin J Med 1989; 56: 253–7

    PubMed  CAS  Google Scholar 

  17. Clements PJ, Davis J. Cytotoxic drugs. Their clinical application to the rheumatic diseases. Seminars Arthritis Rheum 1986; 15: 231–54

    Article  CAS  Google Scholar 

  18. Steinberg AD, Steinberg SC. Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone alone. Arthritis Rheum 1991; 34: 945–50

    Article  PubMed  CAS  Google Scholar 

  19. Rakover Y, Adar H, Tal I, et al. Behçet disease: long-term follow-up of three children and review of the literature. Pediatrics 1989; 83: 986–92

    PubMed  CAS  Google Scholar 

  20. Patten E. Therapeutic plasmapheresis and plasma exchange. Crit Rev Clin Lab Sci 1986; 23: 147–75

    Article  PubMed  CAS  Google Scholar 

  21. Geltner D. Therapeutic approaches in mixed cryoglobulinemia. Springer Semin Immunopathol 1988; 10: 103–13

    Article  PubMed  CAS  Google Scholar 

  22. Lewis EJ, Hunsicker LG, Lan SP, et al. A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med 1992; 326: 1373–9

    Article  PubMed  CAS  Google Scholar 

  23. Wallace D, Goldfinger D, Lowe C, et al. A double blind controlled study of lymphapheresis in rheumatoid arthritis. N Engl J Med 1982; 306: 1406–11

    Article  PubMed  CAS  Google Scholar 

  24. Berkman SA, Martin LL, Gale RP. Clinical uses of IVIG. Ann Intern Med 1990; 112: 278–92

    PubMed  CAS  Google Scholar 

  25. Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991; 324: 1633–9

    Article  PubMed  CAS  Google Scholar 

  26. Dalakas MC, Illa I, Dambrosia JM, et al. A controlled trial of high dose IVIg infusions as treatment for dermatomyositis. N Engl J Med 1993; 329: 1993–2000

    Article  PubMed  CAS  Google Scholar 

  27. Mathieson PW, Cobbold SP, Hale G, et al. Monoclonal antibody therapy in systemic vasculitis. N Engl J Med 1990; 323: 250–4

    Article  PubMed  CAS  Google Scholar 

  28. Lie JT. Primary (granulomatous) angiitis of the CNS. A clinicopathologic analysis of 15 new cases and a review of the literature. Hum Pathol 1992; 23: 164–71

    Article  PubMed  CAS  Google Scholar 

  29. Yankner BA, Skolnik PR, Shoukimas GM, et al. Cerebral granulomatous angiitis associated with isolation of human T-lymphotropic virus type III from the CNS. Ann Neurol 1986; 20: 362–4

    Article  PubMed  CAS  Google Scholar 

  30. Moore PM. Diagnosis and management of IACNS. Neurology 1989; 39: 167–73

    Article  PubMed  CAS  Google Scholar 

  31. Calabrese LH, Mallek JA. Primary angiitis of the central nervous system. Medicine 1987; 67: 20–39

    Google Scholar 

  32. Barron T, Ostrov BE, Zimmerman RA, et al. IACNS: treatment with pulse cyclophosphamide. Pediatr Neurol 1993; 9: 73–5

    Article  PubMed  CAS  Google Scholar 

  33. Kerr GS, Hallahan CW, Giordano J, et al. Takayasu’s arteritis. Ann Intern Med 1994; 120: 919–29

    PubMed  CAS  Google Scholar 

  34. Shelhamer JH, Volkman DJ, Parrillo JE, et al. Takayasu’s arteritis and its therapy. Ann Intern Med 1985; 103: 121–6

    PubMed  CAS  Google Scholar 

  35. Achkar AA, Lie JT, Hunder GG, et al. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med 1994; 120: 987–92

    PubMed  CAS  Google Scholar 

  36. Allen NB, Studenski SA. Polymyalgia rheumatica and temporal arteritis. Med Clin North Am 1986; 70: 369–84

    PubMed  CAS  Google Scholar 

  37. Kato H, Koike S, Yokoyama T. Kawasaki disease. Effect of treatment on coronary artery involvement. Pediatrics 1979; 63: 175–9

    PubMed  CAS  Google Scholar 

  38. Fauci AS, Haynes BF, Katz P, et al. Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98: 76–85

    PubMed  CAS  Google Scholar 

  39. Specks U, Wheatley CL, McDonald TJ, et al. Anticytoplasmic autoantibodies in the diagnosis and follow-up of Wegener’s granulomatosis. Mayo Clin Proc 1989; 64: 28–36

    PubMed  CAS  Google Scholar 

  40. Valeriano-Marcet J, Spiera H. Treatment of Wegener’s granulomatosis with sulfamethoxazole-trimethoprim. Arch Intern Med 1991; 151: 1649–52

    Article  PubMed  CAS  Google Scholar 

  41. O’Duffy JD, Goldstein NP. Neurologic involvement in seven patients with Behçet’s disease. Am J Med 1976; 61: 170–7

    Article  PubMed  Google Scholar 

  42. Yazici H, Pazarli H, Barnes CG, et al. A controlled trial of azathioprine in Behçet’s syndrome. N Engl J Med 1990; 322: 281–5

    Article  PubMed  CAS  Google Scholar 

  43. Lhote F, Guillevin L, Sauvaget F, et al. Treatment of PAN related to hepatitis B virus with alpha interferon and plasma exchanges. Results in six patients [abstract]. Arthritis Rheum 1993; 36: S96

    Google Scholar 

  44. Capiello RA, Espinoza LR, Adelman H, et al. Cholesterol embolism: a pseudovasculitic syndrome. Semin Arthritis Rheum 1989; 18: 240–6

    Article  Google Scholar 

  45. Asherson RA. The catastrophic APLA syndrome. J Rheumatol 1992; 19: 508–12

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric and Adult Rheumatology, Milton S. Hershey Medical Center, Pennsylvania State University School of Medicine, Children’s Hospital/University Hospital, Hershey, Pennsylvania, 17033, USA

    Barbara E. Ostrov

  2. Pediatric Neurology, Milton S. Hershey Medical Center, Pennsylvania State University School of Medicine, Children’s Hospital/University Hospital, Hershey, Pennsylvania, USA

    Todd F. Barron

Authors
  1. Barbara E. Ostrov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Todd F. Barron
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ostrov, B.E., Barron, T.F. Cerebral Vasculitis. CNS Drugs 3, 115–125 (1995). https://doi.org/10.2165/00023210-199503020-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00023210-199503020-00004

Keywords

Search

Navigation